Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Trichoscopy is useful for diagnosing and monitoring male pattern hair loss.

Combining medications with scalp care and lifestyle changes boosts hair growth and reduces medication side effects.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Red fluorescence in AGA scalps is linked to different microbes.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Inflammatory complications are rare after hair transplants but can happen months later, and checking for skin conditions before surgery is important.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

The document says that Androgenetic alopecia, a common hair loss condition, affects women less often and usually less severely, but early diagnosis and treatment are important.

Male pattern baldness in medical students is linked to higher depression, loneliness, and internet addiction.

Iron levels affect sleep apnea severity in people with hair loss, especially women.

No significant link between male pattern baldness and COVID-19 severity was found.

More personalized and effective treatments for androgenetic alopecia are needed.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Nonandrogenic factors like oxidative stress and microinflammation are important in hair loss progression.

Hair follicles convert androgens, affecting hair loss patterns.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Microneedling therapy leads to better treatment adherence than drug therapy for hair loss.

New drug targets for hair loss treatment were identified by studying cell interactions in hair follicles.

Stress worsens hair loss in androgenetic alopecia.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.